Annual Debt To Equity
-1.25
+8.96+87.76%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual debt to equity ratio is -1.25, with the most recent change of +8.96 (+87.76%) on December 31, 2023.
- During the last 3 years, KPTI annual debt to equity has fallen by -3.58 (-153.65%).
- KPTI annual debt to equity is now -153.65% below its all-time high of 2.33, reached on December 31, 2020.
Performance
KPTI Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-1.19
+0.26+17.93%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly debt to equity ratio is -1.19, with the most recent change of +0.26 (+17.93%) on September 30, 2024.
- Over the past year, KPTI quarterly debt to equity has increased by +0.26 (+17.93%).
- KPTI quarterly debt to equity is now -151.07% below its all-time high of 2.33, reached on December 31, 2020.
Performance
KPTI Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
KPTI Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.8% | +17.9% |
| 3 y3 years | -153.7% | +11.2% |
| 5 y5 years | -323.2% | -166.1% |
KPTI Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.8% | -17.8% | +88.3% |
| 5 y | 5-year | -153.7% | +87.8% | -151.1% | +88.3% |
| alltime | all time | -153.7% | +87.8% | -151.1% | +88.3% |
Karyopharm Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1.19(-17.9%) |
| Jun 2024 | - | -1.45(+43.6%) |
| Mar 2024 | - | -1.01(-19.2%) |
| Dec 2023 | -1.25(-87.8%) | -1.25(-26.5%) |
| Sep 2023 | - | -1.70(-28.9%) |
| Jun 2023 | - | -2.39(-36.6%) |
| Mar 2023 | - | -3.77(-63.1%) |
| Dec 2022 | -10.21(+381.6%) | -10.21(+743.8%) |
| Sep 2022 | - | -1.21(-17.1%) |
| Jun 2022 | - | -1.46(-28.4%) |
| Mar 2022 | - | -2.04(-3.8%) |
| Dec 2021 | -2.12(-191.0%) | -2.12(+58.2%) |
| Sep 2021 | - | -1.34(-34.0%) |
| Jun 2021 | - | -2.03(-52.3%) |
| Mar 2021 | - | -4.26(-282.8%) |
| Dec 2020 | 2.33(+5.4%) | 2.33(+68.8%) |
| Sep 2020 | - | 1.38(+56.8%) |
| Jun 2020 | - | 0.88(+31.3%) |
| Mar 2020 | - | 0.67(-69.7%) |
| Dec 2019 | 2.21(+294.6%) | 2.21(+22.8%) |
| Sep 2019 | - | 1.80(+39.5%) |
| Jun 2019 | - | 1.29(+50.0%) |
| Mar 2019 | - | 0.86(+53.6%) |
| Dec 2018 | 0.56 | 0.56(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 0.00(0.0%) |
| Jun 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2017 | - | 0.00(0.0%) |
| Jun 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(0.0%) |
| Jun 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2014 | - | 0.00(0.0%) |
| Jun 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2013 | - | 0.00(0.0%) |
| Jun 2013 | - | 0.00(0.0%) |
| Dec 2012 | 0.00(0.0%) | 0.00 |
| Dec 2011 | 0.00 | - |
FAQ
- What is Karyopharm Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual debt to equity year-on-year change?
- What is Karyopharm Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly debt to equity year-on-year change?
What is Karyopharm Therapeutics annual debt to equity ratio?
The current annual debt to equity of KPTI is -1.25
What is the all time high annual debt to equity for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual debt to equity ratio is 2.33
What is Karyopharm Therapeutics annual debt to equity year-on-year change?
Over the past year, KPTI annual debt to equity ratio has changed by +8.96 (+87.76%)
What is Karyopharm Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of KPTI is -1.19
What is the all time high quarterly debt to equity for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly debt to equity ratio is 2.33
What is Karyopharm Therapeutics quarterly debt to equity year-on-year change?
Over the past year, KPTI quarterly debt to equity ratio has changed by +0.26 (+17.93%)